JP2022553653A5 - - Google Patents
Info
- Publication number
- JP2022553653A5 JP2022553653A5 JP2022521684A JP2022521684A JP2022553653A5 JP 2022553653 A5 JP2022553653 A5 JP 2022553653A5 JP 2022521684 A JP2022521684 A JP 2022521684A JP 2022521684 A JP2022521684 A JP 2022521684A JP 2022553653 A5 JP2022553653 A5 JP 2022553653A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- weight
- highly lipophilic
- physiologically active
- cannabinoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025169943A JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19203580.6 | 2019-10-16 | ||
| EP19203580.6A EP3808341A1 (de) | 2019-10-16 | 2019-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| PCT/EP2020/079248 WO2021074403A1 (de) | 2019-10-16 | 2020-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169943A Division JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553653A JP2022553653A (ja) | 2022-12-26 |
| JP2022553653A5 true JP2022553653A5 (enExample) | 2023-10-19 |
| JP7778069B2 JP7778069B2 (ja) | 2025-12-01 |
Family
ID=68281185
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521684A Active JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
| JP2025169943A Pending JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169943A Pending JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240139215A1 (enExample) |
| EP (2) | EP3808341A1 (enExample) |
| JP (2) | JP7778069B2 (enExample) |
| CN (1) | CN114945353A (enExample) |
| AU (1) | AU2020365443B2 (enExample) |
| BR (1) | BR112022006643A2 (enExample) |
| CA (1) | CA3157654A1 (enExample) |
| IL (1) | IL292018A (enExample) |
| MX (1) | MX2022004523A (enExample) |
| WO (1) | WO2021074403A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3808336A1 (de) * | 2019-10-16 | 2021-04-21 | ADD Advanced Drug Delivery Technologies, Ltd. | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| AU2021400338A1 (en) | 2020-12-17 | 2023-07-13 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| GB2618322A (en) * | 2022-04-29 | 2023-11-08 | 113 Botanicals Ltd | Compositions and methods |
| US12636296B1 (en) | 2025-07-17 | 2026-05-26 | Nalu Bio, Inc. | Cannabinol analogs and their use as pharmacologically active agents |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1361864T3 (en) * | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| JPWO2002069957A1 (ja) * | 2001-03-01 | 2004-07-02 | グレラン製薬株式会社 | フェノフィブラート含有組成物 |
| DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| WO2008024490A2 (en) | 2006-08-24 | 2008-02-28 | Theraquest Biosciences, Inc. | Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
| US9943491B2 (en) | 2013-10-29 | 2018-04-17 | Echo Pharmaceuticals B.V. | Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders |
| WO2015065547A1 (en) * | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
| DE102014213548A1 (de) * | 2014-07-11 | 2016-01-14 | Hans Brammer | Cannabispräparat |
| JP6581649B2 (ja) * | 2014-08-11 | 2019-09-25 | ペロラ ゲーエムベーハーＰｅｒｏｒａ Ｇｍｂｈ | 粒子を含む製剤 |
| IL246790A0 (en) * | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
| US20190201350A1 (en) | 2016-08-15 | 2019-07-04 | Corr-Jensen Inc. | Time release of fat-soluble actives |
| JP2019137614A (ja) * | 2018-02-06 | 2019-08-22 | 富士フイルム株式会社 | 経口用医薬組成物及びその製造方法 |
| DE102019100483A1 (de) * | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oraler Dünnfilm |
-
2019
- 2019-10-16 EP EP19203580.6A patent/EP3808341A1/de not_active Withdrawn
-
2020
- 2020-10-16 BR BR112022006643A patent/BR112022006643A2/pt unknown
- 2020-10-16 CN CN202080072328.8A patent/CN114945353A/zh active Pending
- 2020-10-16 MX MX2022004523A patent/MX2022004523A/es unknown
- 2020-10-16 WO PCT/EP2020/079248 patent/WO2021074403A1/de not_active Ceased
- 2020-10-16 AU AU2020365443A patent/AU2020365443B2/en active Active
- 2020-10-16 JP JP2022521684A patent/JP7778069B2/ja active Active
- 2020-10-16 IL IL292018A patent/IL292018A/en unknown
- 2020-10-16 CA CA3157654A patent/CA3157654A1/en active Pending
- 2020-10-16 US US17/769,424 patent/US20240139215A1/en not_active Abandoned
- 2020-10-16 EP EP20800800.3A patent/EP4045014A1/de active Pending
-
2025
- 2025-10-08 JP JP2025169943A patent/JP2025182116A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3490575B2 (fr) | Extrait de plante tres concentre en safranal, procede d'obtention et utilisations | |
| JP2025182116A5 (enExample) | ||
| CN1615146A (zh) | 生姜提取物制剂 | |
| BR0316595A (pt) | Composto, método para a preparação de compostos, composição farmacêutica e usos do composto | |
| JP7778069B2 (ja) | 高親油性生理活性物質の放出制御製剤 | |
| CN110833531A (zh) | 一种维生素e制剂及其制备方法 | |
| JP2019524724A (ja) | テコビリマットの経口用医薬組成物及びその調製法 | |
| EP1994926B9 (en) | Valsartan formulations | |
| CN103385876B (zh) | 一种夫罗曲坦的药物组合物及其制备方法 | |
| JPWO2019004449A1 (ja) | 医薬組成物 | |
| CN104870544B (zh) | 用于形成复合物的组合物、由此形成的复合物和用于口服的含所述复合物的组合物 | |
| JP2022553652A5 (enExample) | ||
| do Nascimento et al. | Preparation and characterization of microcapsules loaded with polyphenols-enriched Uncaria tomentosa extract using spray-dryer technique | |
| JP2020525424A (ja) | テルミナリア・アルジュナの樹皮からのアルジュングルコシドの標準化組成物の調製のための方法 | |
| JP2009501214A (ja) | クロピドグレルビスルファートを含有する薬学的組成物 | |
| JP5698395B2 (ja) | 結晶及び該結晶を含有してなる医薬製剤 | |
| Al-Pokhiti et al. | Development and evaluation of sustained release matrix tablets of ketoprofen employing natural polymers (pomegranate peel and acacia powders) | |
| CN115715764B (zh) | 一种阿帕替尼口腔贴片及其制备方法 | |
| KR101083873B1 (ko) | 애엽에 함유되어 있는 혈액응고 억제작용을 갖는 성분의 제거방법 | |
| CN109419780B (zh) | 一种盐酸索他洛尔片剂及其制备方法 | |
| CN101222929A (zh) | 银杏提取物 | |
| AU2020366134B2 (en) | Controlled release formulations of highly lipophilic physiologically active substances | |
| CN104688695A (zh) | 一种含有伏立康唑的药物组合物 | |
| KR100541249B1 (ko) | 수리취추출물을 유효성분으로 함유하는 항류마티스 효과를 가지는 조성물 | |
| Reddy et al. | Conception and Evaluation of Gemfibrozil as Immediate Drug Delivery System |